Skip to content

Stat Profile M Analyzer

by Nova Biomedical Corp.

510(k) K981427

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None ongoing

1 closed

Documents

Trust

Unverified

Source FDA 510(k), synced 5 Oct 2026.

Regulatory status

as of registry sync 5 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK981427 Date12 May 1998ClearedStatusActive

Official records

From the FDA record

Received by the FDA
16 Apr 1998
FDA decision
12 May 1998 (Substantially Equivalent)
FDA review time
26 days from receipt to decision
Public document
510(k) statement on file with the FDA

From the FDA 510(k) record K981427 (openFDA), as read on 5 Oct 2026. Quoted as published, gaps included; nothing on this list is generated.

Recalls

1 recall · FDA

    • Terminated Z-0060-04 FDA Unclassified (pre-2012) initiated 22 Sep 2003 on shared 510(k) K981427

    Degradation of the magnesium sensor could result in low ionozed magnesium patient samples

Recalls on a shared submission name another device cleared under the same FDA submission as this one.

Timeline

2 dated events

  1. Cleared FDA 510(k) K981427
  2. Recall initiated FDA recalls Z-0060-04

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA product code
GKF
Device class
Class II
Regulation
21 CFR Part 864.5600
Advisory committee
Hematology
FDA decision
SESE Substantially Equivalent

Overview

AI-generated summary, 1 Oct 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The Stat Profile M Analyzer is an automated hematology instrument designed for rapid, whole-blood analysis in critical care settings. Classified as a Hematocrit device under the FDA’s Hematology advisory committee, it performs automated measurements to support clinical decision-making in acute patient care. Its primary function aligns with OpenFDA’s device classification as an automated hematology analyzer, enabling efficient hematological assessments without manual intervention.

This device is intended for use in hospital or clinical laboratory environments, where single-use reagents and disposable test cartridges are employed for each analysis. Supplied sterile and intended for single-use, it operates within FDA-cleared parameters under 510(k) clearance (K981427) and adheres to Class II regulatory standards (864.5600). Storage requires adherence to manufacturer guidelines, and its maintenance-free design reduces operational complexity. No MRI safety labeling is indicated in the regulatory data.

Similar devices

Other devices filed under FDA product code GKF (Instrument, Hematocrit, Automated).

Other devices from Nova Biomedical Corporation

See all devices from Nova Biomedical Corporation →